The FDA has accepted the new drug application (NDA) for tirabrutinib (ONO-4059), a highly selective, irreversible, second-generation Bruton tyrosine kinase (BTK) inhibitor developed for the treatment ...
Whether you are looking to step onto a professional film set or take the next step in your career behind the scenes, this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results